Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
Seer (Nasdaq: SEER), a company focused on proteomic insights, has announced its participation in the Canaccord Genuity 45th Annual Growth Conference in Boston. The company's management will engage in a fireside chat on August 13th at 9:00 a.m. ET.
Investors can access the presentation through a live webcast on the Investor section of Seer's website at investor.seer.bio, with an archived replay available after the event.
Seer (Nasdaq: SEER), un'azienda specializzata in approfondimenti proteomici, ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Crescita di Canaccord Genuity a Boston. Il management dell'azienda prenderà parte a una conversazione informale il 13 agosto alle 9:00 ET.
Gli investitori potranno seguire la presentazione tramite una diretta streaming nella sezione Investor del sito di Seer, all'indirizzo investor.seer.bio, con una registrazione disponibile dopo l'evento.
Seer (Nasdaq: SEER), una empresa enfocada en conocimientos proteómicos, ha anunciado su participación en la 45ª Conferencia Anual de Crecimiento de Canaccord Genuity en Boston. La dirección de la compañía participará en una charla informal el 13 de agosto a las 9:00 a.m. ET.
Los inversores podrán acceder a la presentación a través de una transmisión en vivo en la sección de inversores del sitio web de Seer, en investor.seer.bio, con una repetición archivada disponible después del evento.
Seer (나스닥: SEER)는 단백질체 통찰력에 중점을 둔 회사로, 보스턴에서 열리는 Canaccord Genuity 제45회 연례 성장 컨퍼런스에 참가할 예정입니다. 회사 경영진은 8월 13일 오전 9시(동부시간)에 파이어사이드 채팅에 참여합니다.
투자자들은 Seer 웹사이트의 투자자 섹션 investor.seer.bio에서 라이브 웹캐스트로 발표를 시청할 수 있으며, 행사 후에는 녹화본도 제공됩니다.
Seer (Nasdaq : SEER), une entreprise spécialisée dans les analyses protéomiques, a annoncé sa participation à la 45e Conférence Annuelle de Croissance Canaccord Genuity à Boston. La direction de la société participera à une discussion informelle le 13 août à 9h00 ET.
Les investisseurs pourront suivre la présentation via une webdiffusion en direct dans la section Investisseurs du site de Seer, à l'adresse investor.seer.bio, avec une rediffusion disponible après l'événement.
Seer (Nasdaq: SEER), ein Unternehmen mit Fokus auf proteomische Erkenntnisse, hat seine Teilnahme an der 45. jährlichen Wachstumskonferenz von Canaccord Genuity in Boston angekündigt. Das Management des Unternehmens wird am 13. August um 9:00 Uhr ET an einem Fireside-Chat teilnehmen.
Investoren können die Präsentation über einen Live-Webcast im Investor-Bereich der Seer-Website unter investor.seer.bio verfolgen, mit einer aufgezeichneten Wiedergabe, die nach der Veranstaltung verfügbar ist.
- None.
- None.
REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual Growth Conference in Boston, MA.
Seer’s management is scheduled to participate in a fireside chat on Wednesday, August 13th at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.
About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with a scale, speed, precision, and reproducibility previously unattainable. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others cannot. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visit www.seer.bio.
Media Contact:
Consort Partners
pr@seer.bio
Investor Inquiries:
Carrie Mendivil
investor@seer.bio
FAQ
When is Seer (SEER) presenting at the Canaccord Genuity Growth Conference?
How can investors watch Seer's presentation at the Canaccord conference?
What is the location of the Canaccord Genuity Conference where Seer is presenting?
What type of company is Seer (SEER)?
